Job title: Supply Chain Director, Cell Therapy
Chris Baldwin is the Supply Chain Director for Cell Therapy Products at GSK and is accountable for the vein to vein supply chain for T-Cell Immuno-Oncology products covering a network of apheresis collection centers, manufacturing sites and treatment centers. His team covers managing inventory, logistics, labelling, tracking, site on-boarding and coordinating the cellular supply chain across sites. In previous roles, he has lead teams to design and build supply chains for complex biological products including mRNA vaccines, Biosimilars and Antibody Drug Conjugates. Chris holds a PhD from University of Cambridge and a Masters from University College, London.
Next Steps to Advance the Field and Implement Standardized Practice for Cell Therapy Supply Chain and Logistics 1:30 pm
Reflecting on the key takeaways from the summit to hold guided discussion on next steps to advance the industry and progress standards and harmonization in cell therapy supply chain and logistics Discussing how to standardize the chain of custody and chain of identity for efficient patient and product tracking Creating standards at the cell collection…Read more
day: Day Two
Breakfast Panel: What does the Future Landscape of Cell Therapy Look Like? How Can Supply and Logistics Organizations Prepare to Scale? 8:15 am
Discussing the future landscape of cell therapy, the market potential, and drawing a roadmap to ramp up supply in a sustainable and standardized manner Highlighting the key challenges to date in cell therapy supply, and how a culture of co-petition can advance the industry Taking aim at ‘best practice’ in supply chain and logistics, from…Read more
day: Day One